Search research articles
Contact Us
Filters
Showing results (511-520 of 523) with videos related to
Page
of 53
Sort By:
Nature Genetics
|
December 8, 2020
Insights into the genetic architecture of the human face
Julie D White, Karlijne Indencleef, Sahin Naqvi, et al.
Annals of Internal Medicine
|
August 8, 2022
Reinfection and Risk Behaviors After Treatment of Hepatitis C Virus Infection in Persons Receiving Opioid Agonist Therapy : A Cohort Study
Jason Grebely, Gregory J Dore, Frederick L Altice, et al.
Circulation. Genomic and Precision Medicine
|
June 19, 2019
Clinical Implications of Identifying Pathogenic Variants in Individuals With Thoracic Aortic Dissection
Brooke N Wolford, Whitney E Hornsby, Dongchuan Guo, et al.
The International Journal on Drug Policy
|
July 8, 2017
Research priorities to achieve universal access to hepatitis C prevention, management and direct-acting antiviral treatment among people who inject drugs
Jason Grebely, Julie Bruneau, Jeffrey V Lazarus, et al.
BMC Genetics
|
July 19, 2019
Meta-analysis of GWA studies provides new insights on the genetic architecture of skin pigmentation in recently admixed populations
Frida Lona-Durazo, Natalia Hernandez-Pacheco, Shaohua Fan, et al.
Leukemia
|
February 24, 2001
Long-term results of three randomized trials (58831, 58832, 58881) in childhood acute lymphoblastic leukemia: a CLCG-EORTC report. Children Leukemia Cooperative Group
E Vilmer, S Suciu, A Ferster, et al.
Science (New York, N.Y.)
|
December 17, 2005
SLC24A5, a putative cation exchanger, affects pigmentation in zebrafish and humans
Rebecca L Lamason, Manzoor-Ali P K Mohideen, Jason R Mest, et al.
Breast (Edinburgh, Scotland)
|
March 20, 2012
1st International consensus guidelines for advanced breast cancer (ABC 1)
F Cardoso, A Costa, L Norton, et al.
The Lancet. Gastroenterology & Hepatology
|
November 12, 2022
Patient-centred models of hepatitis C treatment for people who inject drugs: a multicentre, pragmatic randomised trial
Alain H Litwin, Paula J Lum, Lynn E Taylor, et al.
JAMA Network Open
|
August 26, 2024
Hepatitis C Virus Reinfection Among People Who Inject Drugs: Long-Term Follow-Up of the HERO Study
Alain H Litwin, Judith I Tsui, Moonseong Heo, et al.
Page
of 53
Search research articles
Search
Showing results (511-520 of 523) with videos related to
Sort By:
Page
of 53
Nature Genetics
|
December 8, 2020
Insights into the genetic architecture of the human face
Julie D White, Karlijne Indencleef, Sahin Naqvi, et al.
Annals of Internal Medicine
|
August 8, 2022
Reinfection and Risk Behaviors After Treatment of Hepatitis C Virus Infection in Persons Receiving Opioid Agonist Therapy : A Cohort Study
Jason Grebely, Gregory J Dore, Frederick L Altice, et al.
Circulation. Genomic and Precision Medicine
|
June 19, 2019
Clinical Implications of Identifying Pathogenic Variants in Individuals With Thoracic Aortic Dissection
Brooke N Wolford, Whitney E Hornsby, Dongchuan Guo, et al.
The International Journal on Drug Policy
|
July 8, 2017
Research priorities to achieve universal access to hepatitis C prevention, management and direct-acting antiviral treatment among people who inject drugs
Jason Grebely, Julie Bruneau, Jeffrey V Lazarus, et al.
BMC Genetics
|
July 19, 2019
Meta-analysis of GWA studies provides new insights on the genetic architecture of skin pigmentation in recently admixed populations
Frida Lona-Durazo, Natalia Hernandez-Pacheco, Shaohua Fan, et al.
Leukemia
|
February 24, 2001
Long-term results of three randomized trials (58831, 58832, 58881) in childhood acute lymphoblastic leukemia: a CLCG-EORTC report. Children Leukemia Cooperative Group
E Vilmer, S Suciu, A Ferster, et al.
Science (New York, N.Y.)
|
December 17, 2005
SLC24A5, a putative cation exchanger, affects pigmentation in zebrafish and humans
Rebecca L Lamason, Manzoor-Ali P K Mohideen, Jason R Mest, et al.
Breast (Edinburgh, Scotland)
|
March 20, 2012
1st International consensus guidelines for advanced breast cancer (ABC 1)
F Cardoso, A Costa, L Norton, et al.
The Lancet. Gastroenterology & Hepatology
|
November 12, 2022
Patient-centred models of hepatitis C treatment for people who inject drugs: a multicentre, pragmatic randomised trial
Alain H Litwin, Paula J Lum, Lynn E Taylor, et al.
JAMA Network Open
|
August 26, 2024
Hepatitis C Virus Reinfection Among People Who Inject Drugs: Long-Term Follow-Up of the HERO Study
Alain H Litwin, Judith I Tsui, Moonseong Heo, et al.
Page
of 53